Vered Bisker-Leib

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Vered Bisker-Leib
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vered Bisker-Leib:

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Compass Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,124,426
Estimated value
$4,530,418
Report date
08 Feb 2024
Price
$1.45
Ownership
Direct
Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Compass Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
1,753,125
Estimated value
Report date
09 Jan 2024
Price
Ownership
Direct
Underlying class
CommonStock
Underlying amount
Form 4 holding Director

Ayala Pharmaceuticals, Inc.

Security class
Stock Option
Shares / value
1,171
Estimated value
Report date
19 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Old Ayala, Inc

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
19 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Vered Bisker-Leib

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .